Table 1.
Patient characteristics
| Total samples (N = 105) | Outpatients (N = 55, 52.3%) | Inpatients (N = 50, 47.7%) | p-value | |
|---|---|---|---|---|
| Sex (male/female)a | 48/57 | 22/33 | 26/24 | 0.244 |
| Age (mean ± SD) b | 47.0 ± 13.3 | 47.8 ± 14.2 | 46.1 ± 12.4 | 0.529 |
| Diagnosisa | ||||
| Schizophrenia | 103 | 54 | 48 | 1 |
| Schizoaffective disorder | 2 | 0 | 2 | |
| Delusional disorder | 1 | 1 | 0 | |
| Age of onset (mean ± SD) b | 28.8 ± 11.5 | 30.2 ± 11.7 | 27.3 ± 11.1 | 0.156 |
| Duration of hospitalization (at time of assessment, mean ± SD, days) | 53.0 ± 66.0 | 53.0 ± 66.0 | ||
| Number of hospitalizations b | 4.0 ± 5.1 | 3.5 ± 4.7 | 4.7 ± 5.5 | 0.528 |
| Years of educationa | 0.912 | |||
| ≤ 9 | 36 | 18 | 18 | |
| > 9- ≤ 12 | 36 | 20 | 16 | |
| > 12 | 32 | 17 | 15 | |
| Marital statea | ||||
| Single | 71 | 34 | 37 | 0.372 |
| Married | 20 | 13 | 7 | |
| Divorced | 14 | 8 | 6 | |
| Widow | 1 | 1 | 0 | |
| Partnersa | ||||
| Yes | 84 | 45 | 39 | 0.635 |
| No | 21 | 10 | 11 | |
|
Antipsychotic medicationb Antipsychotic dose (SGA + FGA) (CP equivalent, mean ± SD, mg/day) |
617.2 ± 349.9 | 558.1 ± 360.0 | 682.2 ± 323.0 | 0.67 |
| Antipsychotic dose of SGA (CP equivalent, mean ± SD, mg/day) | 582.8 ± 337.5 | 533.2 ± 352.8 | 637.4 ± 316.7 | 0.114 |
| Antipsychotic dose of FGA (CP equivalent, mean ± SD, mg/day) | 34.9 ± 108.23 | 24.9 ± 84.6 | 44.8 ± 129.5 | 0.351 |
a Fisher’s exact test p-value for the difference in sex, diagnosis, years of education, marital status, and partners between the two groups
b Unpaired t-test p-value for the difference in age between the two groups
AQ Autism-Spectrum Quotient, CP Chlorpromazine, FGA First-generation antipsychotics, IMSI Internalized Stigma of Mental Illness, QIDS, Quick Inventory of Depressive Symptomatology, RAS Recovery Assessment Scale, SGA Second-generation antipsychotics